Actinium Pharmaceuticals strengthens its leadership team with a new business development head to drive strategic licensing and commercial growth in the radiopharmaceutical space.
Appointment of a radiopharmaceutical industry veteran to lead business development may strengthen future partnering and licensing efforts, but no immediate financial impact.
Actinium Pharmaceuticals has hired a seasoned oncology executive with over 20 years of experience to spearhead its business development initiatives. The appointment aims to bolster the company's strategic partnering, licensing, and transaction efforts within the radiopharmaceutical sector.
The appointment is intended to lead and expand the company's partnering, licensing, and strategic transaction efforts.